TF and lung carcinoma: Expanding on this concept, transferrin-conjugated, doxorubicin-loaded, lipid-coated poly d,l-lactic-co-glycolic acid nanoparticles (TF-LPs) were developed as targeted vectors for lung cancer therapy.